The Swiss therapeutic products agency has begun reviewing another anti-Covid 19 vaccine in the rolling submission procedure. Swissmedic said the United States pharmaceutical company Pfizer ...

ST. GALLEN, Switzerland and SAN DIEGO, Oct. 17, 2024 /PRNewswire/ -- CSL Vifor and Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that Swissmedic has granted temporary marketing ...

Thanks to our increase in capacity and ongoing launch expansion. In the third quarter, CARVYKTI became commercially available ...

Vortioxetine, which is already approved by the FDA in the U.S. and Swissmedic, has the crucial ability to cross the ...

Just over a year ago, New Zealand customs officials started to intercept batches of injectable medications labelled Fitaro ...

After tech helped the MHRA play a starring role in government’s coronavirus response, digital chief Claire Harrison tells Sam ...

Swissmedic has warned against buying drugs from unreliable sources, particularly from abroad, after reports of hospitalisations in connection with falsified injectables of Ozempic. The medicine ...

Announced plans for new, state-of-the-art cell therapy R&D facility in Philadelphia Cash and cash equivalents, and time deposits of $1.2 billion, as of September 30, 2024, which Legend Biotech ...

"Swissmedic approval further demonstrates our promise to deliver transformational medicines for patients with serious diseases in our areas of focus," said Emmanuelle Lecomte Brisset, Senior Vice ...

Temporary marketing authorization is based on statistically significant and clinically meaningful results from the Phase 3 PROTECT TrialSAN DIEGO, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Travere ...